195 related articles for article (PubMed ID: 11229475)
21. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
22. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
24. Self Ig peptides that help anti-DNA antibody production: importance of charged residues.
Hahn BH; Singh RR; Ebling FM
Lupus; 1998; 7(5):307-13. PubMed ID: 9696134
[TBL] [Abstract][Full Text] [Related]
25. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
Borel Y; Lewis RM; André-Schwartz J; Stollar BD; Diener E
J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453
[TBL] [Abstract][Full Text] [Related]
26. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
[TBL] [Abstract][Full Text] [Related]
27. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies.
Tsao BP; Chow A; Cheroutre H; Song YW; McGrath ME; Kronenberg M
Eur J Immunol; 1993 Sep; 23(9):2332-9. PubMed ID: 8370409
[TBL] [Abstract][Full Text] [Related]
28. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus.
Singh RR; Kumar V; Ebling FM; Southwood S; Sette A; Sercarz EE; Hahn BH
J Exp Med; 1995 Jun; 181(6):2017-27. PubMed ID: 7539036
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells pulsed with apoptotic cells activate self-reactive T-cells of lupus mice both in vitro and in vivo.
Tzeng TC; Suen JL; Chiang BL
Rheumatology (Oxford); 2006 Oct; 45(10):1230-7. PubMed ID: 16595513
[TBL] [Abstract][Full Text] [Related]
30. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
[TBL] [Abstract][Full Text] [Related]
31. Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells: implication in autoimmune disease pathogenesis and B cell tolerance.
Lou YH; McElveen MF; Garza KM; Tung KS
J Immunol; 1996 May; 156(9):3535-40. PubMed ID: 8617983
[TBL] [Abstract][Full Text] [Related]
32. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.
Portanova JP; Claman HN; Kotzin BL
J Immunol; 1985 Dec; 135(6):3850-6. PubMed ID: 3877758
[TBL] [Abstract][Full Text] [Related]
33. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
Liu SD; Lee S; La Cava A; Motran CC; Hahn BH; Miceli MC
Lupus; 2011 Apr; 20(5):473-84. PubMed ID: 21335401
[TBL] [Abstract][Full Text] [Related]
34. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
Singh RR; Ebling FM; Sercarz EE; Hahn BH
J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
[TBL] [Abstract][Full Text] [Related]
35. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
Bahjat FR; Pine PR; Reitsma A; Cassafer G; Baluom M; Grillo S; Chang B; Zhao FF; Payan DG; Grossbard EB; Daikh DI
Arthritis Rheum; 2008 May; 58(5):1433-44. PubMed ID: 18438845
[TBL] [Abstract][Full Text] [Related]
36. Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR x NZB)F1 murine model.
Stoll ML; Price KD; Silvin CJ; Jiang F; Gavalchin J
J Autoimmun; 2007 Aug; 29(1):30-7. PubMed ID: 17459659
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Wu HY; Monsonego A; Weiner HL
J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
[TBL] [Abstract][Full Text] [Related]
38. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
Fournel S; Muller S
Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
[TBL] [Abstract][Full Text] [Related]
39. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
[TBL] [Abstract][Full Text] [Related]
40. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
